John B Sanfilippo & Son
JBSS · NASDAQ
About JBSS
- Employees
- 1,900
- Headquarters
- Elgin, Illinois
- Listed
- Dec 4, 1991
- Sector
- Consumer Staples
- Industry
- Food Products
- Website
- jbssinc.com
JBSS key statistics
- Market cap
- 768.61M
- Price-earnings ratio
- 12.50
- Dividend yield
- 6.05%
- Average volume
- 126.57K
- Volume
- 115.11K
- Open price
- $65.95
- High today
- $66.94
- Low today
- $65.49
- 52 Week high
- $92.08
- 52 Week low
- $59.07
John B Sanfilippo & Son (JBSS) at a glance
As of Oct 20, 2026, John B Sanfilippo & Son (JBSS) shares are priced at $65.73, giving the company a market cap of 768.61M, a price-to-earnings ratio of 12.50 and a dividend yield of 6.05%.
Today the stock has traded between $65.49 and $66.94. The current price is 0.4% above the day's low and 1.8% below its high.
Volume so far is 115.11K shares, in line with the average of 126.57K shares a day.
Over the past year John B Sanfilippo & Son has ranged from $59.07 to $92.08, and now sits 20% of the way up that range.
John B Sanfilippo & Son met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.71 per share against an estimate of $1.20.
The average analyst price target is $102.00, 55.2% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $91.91
- Now
- $65.73
- High
- $114.45
JBSS earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 3.0% on average.
- Q4 FY24: reported $0.86 per share against an estimate of $0.00
- Q3 FY24: reported $1.15 per share against an estimate of $0.00
- Q1 FY25: reported $1.00 per share against an estimate of $0.00
- Q2 FY25: reported $1.16 per share against an estimate of $0.00
- Q3 FY25: reported $1.72 per share against an estimate of $0.00
- Q4 FY25: reported $1.15 per share against an estimate of $0.00
- Q1 FY26: reported $1.43 per share against an estimate of $1.18
- Q2 FY26: reported $0.71 per share against an estimate of $1.20
JBSS news
- Avi Kapoor
- Avi Kapoor
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
- Press releaseBusiness Wire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Fourth Quarter and Full Year Results
- Press releaseBusiness Wire
John B. Sanfilippo & Son, Inc. Announces CEO Transition and Leadership Changes
- Press releaseBusiness Wire
John B. Sanfilippo & Son, Inc. Declares $1.05 Per Share Special Dividend and a Regular Annual Dividend of $0.95 Per Share
- Press releaseBusiness Wire
John B. Sanfilippo & Son to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th & 11th in New York, NY
- Press releaseBusiness Wire
John B. Sanfilippo & Son, Inc. Voluntarily Recalls Snack Mix Products Due to Possible Health Risk
- Press releaseBusiness Wire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Third Quarter Results
Similar companies
Companies in the same industry as John B Sanfilippo & Son
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.